BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12902861)

  • 1. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas.
    Bloomer CW; Kenyon L; Hammond E; Hyslop T; Andrews DW; Curran WJ; Dicker AP
    Am J Clin Oncol; 2003 Aug; 26(4):S75-80. PubMed ID: 12902861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade.
    Lin CC; Kenyon L; Hyslop T; Hammond E; Andrews DW; Curran WJ; Dicker AP
    Am J Clin Oncol; 2003 Aug; 26(4):S98-102. PubMed ID: 12902865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in human pituitary tumors.
    Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV
    Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
    Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
    Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
    Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
    J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the epidermal growth factor receptor in optic nerve astrocytes leads to early and transient induction of cyclooxygenase-2.
    Zhang X; Neufeld AH
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2035-41. PubMed ID: 15914620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
    Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA
    Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
    Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas.
    Araki K; Hashimoto K; Ardyanto TD; Osaki M; Shomori K; Nakamura H; Ito H
    Lung Cancer; 2004 Aug; 45(2):161-9. PubMed ID: 15246187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
    Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
    J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.
    Edwards JG; Faux SP; Plummer SM; Abrams KR; Walker RA; Waller DA; O'Byrne KJ
    Clin Cancer Res; 2002 Jun; 8(6):1857-62. PubMed ID: 12060628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands.
    Moraitis D; Du B; De Lorenzo MS; Boyle JO; Weksler BB; Cohen EG; Carew JF; Altorki NK; Kopelovich L; Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2005 Jan; 65(2):664-70. PubMed ID: 15695412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
    Koki AT; Khan NK; Woerner BM; Seibert K; Harmon JL; Dannenberg AJ; Soslow RA; Masferrer JL
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):13-8. PubMed ID: 12051953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
    Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
    Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.